Eagle Bay Advisors’s Zymergen Inc. Common Stock ZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-159
Closed -$1K – 1035
2022
Q3
$1K Hold
159
– – ﹤0.01% 897
2022
Q2
$196 Buy
+159
New +$267 ﹤0.01% 1066
2022
Q1
– Sell
-159
Closed -$1K – 1050
2021
Q4
$1K Hold
159
– – ﹤0.01% 1087
2021
Q3
$2K Hold
159
– – ﹤0.01% 1016
2021
Q2
$7K Buy
+159
New +$6.28K 0.01% 722

Eagle Bay Advisors's ZY Position: Q4 2022 in Review

Eagle Bay Advisors sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 159 shares — an estimated $1K sold.

Eagle Bay Advisors first reported a position in ZY in Q2 2021 and held it in 5 quarters. The position peaked at $7K in Q2 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

  • Eagle Bay Advisors reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Eagle Bay Advisors sold 159 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $1K.
  • Eagle Bay Advisors first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 5 quarters.
  • Eagle Bay Advisors's Zymergen Inc. Common Stock position peaked at $7K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on Eagle Bay Advisors's 13F filing for Q4 2022, filed 26 Jan 2023.